Laurie J. Hall Trustee’s Pacific Biosciences PACB Stock Holding History

Laurie J. Hall Trustee’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-88,185	Closed	-$803K	–	320
2022 Q1	$803K	Buy	+88,185	New	+$1.02M	0.31%	63

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Laurie J. Hall Trustee's PACB Position: Q2 2022 in Review

Laurie J. Hall Trustee sold out of Pacific Biosciences (PACB) in Q2 2022, closing a stake of 88,185 shares — an estimated $803K sold.

Laurie J. Hall Trustee first reported a position in PACB in Q1 2022 and held it in 1 quarter. The position peaked at $803K in Q1 2022. 229 funds tracked by Wall St. Rank hold PACB as of Q2 2022.

Laurie J. Hall Trustee reported no remaining Pacific Biosciences position as of Q2 2022 after selling out during the quarter.
Laurie J. Hall Trustee sold 88,185 Pacific Biosciences shares in Q2 2022, an estimated $803K.
Laurie J. Hall Trustee first reported a position in Pacific Biosciences in Q1 2022 and held it in 1 quarter.
Laurie J. Hall Trustee's Pacific Biosciences position peaked at $803K in Q1 2022.
229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2022.

Based on Laurie J. Hall Trustee's 13F filing for Q2 2022, filed 6 Jul 2022.